title: Detection of group B Streptococcus. Comparison of solid and liquid culture media with and without selective antibiotics.
abstract: A total of 952 consecutive vaginal swabs were obtained from patients who attended obstetric or gynecologic clinics affiliated with the Children's Hospital of Buffalo, New York. Swabs were cultured comparatively on 5% sheep blood agar (BA), selective sheep blood agar containing 1.25 micrograms/ml trimethoprim-23.75 micrograms/ml sulfamethoxazole (SXT), and Lim broth (Todd-Hewitt broth containing 1% yeast extract, 10 micrograms/ml colistin, and 15 micrograms/ml nalidixic acid). A total of 168 swabs (18%) were positive (by at least one method) for group B Streptococcus (GBS). The overall agreement among the three techniques was 90% (858 of 952); 94 specimens (10%, 94 of 952) had discrepant results, and 74 of these (44%, 74 of 168) were positive, only by Lim as opposed to two (1%) and 0 by BA and SXT, respectively. There were only two (2%, 2 of 168) false negative for Lim as compared with 82 (49%) for BA and 86 (51%) for SXT. Thus, the sensitivity of GBS detection by BA, SXT, and Lim is 51%, 49%, and 99%, respectively. These data suggest that the use of Lim broth increases the recovery rate of GBS by 48% after 48 h while the use of the SXT plate reduced the recovery rate by 2% as compared with the conventional BA plate.
authors.affiliation: Department of Pediatrics, State University of New York, Buffalo.
authors.forename: S S
authors.initials: SS
authors.lastname: Altaie
authors.forename: D
authors.initials: D
authors.lastname: Dryja
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003091:Colistin / Q000494:pharmacology; D003470:Culture Media; D005260:Female; D006801:Humans; D009268:Nalidixic Acid / Q000494:pharmacology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013290:Streptococcal Infections / Q000175:diagnosis*; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000302:isolation & purification*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology; D014621:Vagina / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D003470:Culture Media; D009268:Nalidixic Acid; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003091:Colistin